Optimal Stopping Ages for Colorectal Cancer Screening

Matthias Harlass(Erasmus MC), Reinier G.S. Meester(Erasmus MC), Jessica Chubak(Kaiser Permanente Washington Health Research Institute), Douglas A. Corley(Kaiser Permanente), Natalia Udaltsova(Kaiser Permanente), Rosita van den Puttelaar(Erasmus MC), Nicholson Collier(Argonne National Laboratory), Jonathan Ozik(Argonne National Laboratory), Ronit R. Dalmat(University of Washington), Iris Lansdorp‐Vogelaar(Erasmus University Rotterdam), Christopher D. Jensen(Kaiser Permanente)

JAMA Network Open

December 19, 2024

10.1001/jamanetworkopen.2024.51715

Cited by 4

Related Papers

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

|Journal of the American College of Cardiology|2011|851

A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.

|Gastroenterology|2004|526

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation

|Circulation|2009|447

A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score

|Journal of the American Heart Association|2013|407

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

|Gastroenterology|2012|378